ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,234, issued on Dec. 30, was assigned to ALBIREO AB (Gothenburg, Sweden).
"Pharmaceutical formulation of odevixibat" was invented by Eva Byrod (Molndal, Sweden), Per-Goran Gillberg (Molndal, Sweden), Anna-Maria Tivert (Gothenburg, Sweden), Rikard Bryland (Limhamn, Sweden), Ann-Charlotte Dahlquist (Lund, Sweden), Jessica Elversson (Dalby, Sweden), Nils Ove Gustafsson (Loddekopinge, Sweden), Robert Lundqvist (Halso, Sweden), Ingvar Ymen (Saltsjo-Boo, Sweden) and Martin Bohlin (Johanneshov, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a pharmaceutical formulation, e.g. a paediatric formulation, of odevixibat, which comp...